Cargando…

Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma

Background: Glioma is one of the most aggressive cancer types affecting the central nerve system, with poor overall survival (OS) rates. The present study aimed to construct a novel immune-related signature to predict prognosis and the efficiency of immunotherapy in patients with glioma. Methods: Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Sibin, Xiao, Xu, Wang, Yu, Song, Tianjun, Li, Chenlong, Bao, Hongbo, Liu, Qing, Sun, Guiyin, Sun, Xiaoyang, Su, Tianqi, Fu, Tianjiao, Wang, Yujie, Liang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204856/ https://www.ncbi.nlm.nih.gov/pubmed/35719378 http://dx.doi.org/10.3389/fgene.2022.899125

Ejemplares similares

Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma
por: Zhang, Sibin, et al.
Publicado: (2022)

Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment
por: Liu, Qing, et al.
Publicado: (2023)

Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
por: Cong, Tianhao, et al.
Publicado: (2022)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

SYK Is Associated With Malignant Phenotype and Immune Checkpoints in Diffuse Glioma
por: Zhou, Quanwei, et al.
Publicado: (2022)

Prognostic RNA-editing signature predicts immune functions and therapy responses in gliomas
por: He, Yi, et al.
Publicado: (2023)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Prognostic risk of immune-associated signature in the microenvironment of brain gliomas
por: Tao, Yaling, et al.
Publicado: (2023)

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020)

Cuproptosis-related gene signature stratifies lower-grade glioma patients and predicts immune characteristics
por: Zhang, Zihao, et al.
Publicado: (2022)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022)

Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma
por: Sun, Rui, et al.
Publicado: (2022)

Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma
por: Hu, Tianhao, et al.
Publicado: (2022)

PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2022)

Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis
por: Zhang, Zhe, et al.
Publicado: (2023)

A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma
por: Jiang, Cheng, et al.
Publicado: (2023)

A Novel Signature Constructed by Immune-Related LncRNA Predicts the Immune Landscape of Colorectal Cancer
por: Sun, Mengyu, et al.
Publicado: (2021)

An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas
por: Zhou, Kangjie, et al.
Publicado: (2022)

A novel gene signature based on five immune checkpoint genes predicts the survival of glioma
por: Zhang, Wei, et al.
Publicado: (2021)

An immune signature to predict the prognosis of ATRX-wildtype glioma patients and guide immune checkpoint blockade therapy
por: Cao, Wenpeng, et al.
Publicado: (2023)

Reclassifying TNM stage I/II colorectal cancer into two subgroups with different overall survival, tumor microenvironment, and response to immune checkpoint blockade treatment
por: Liu, Xiangxiang, et al.
Publicado: (2022)

Identification of a Six-Immune-Related Long Non-coding RNA Signature for Predicting Survival and Immune Infiltrating Status in Breast Cancer
por: Li, Zheng, et al.
Publicado: (2020)

An Integrated Immune-Related Bioinformatics Analysis in Glioma: Prognostic Signature’s Identification and Multi-Omics Mechanisms’ Exploration
por: Fan, Xin, et al.
Publicado: (2022)

The role of costimulatory molecules in glioma biology and immune microenvironment
por: Wang, Ji, et al.
Publicado: (2022)

Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapy
por: Li, Zhe, et al.
Publicado: (2022)

N6-methyladenosine related gene expression signatures for predicting the overall survival and immune responses of patients with colorectal cancer
por: Yu, Lili, et al.
Publicado: (2023)

The Predictive Role of Immune Related Subgroup Classification in Immune Checkpoint Blockade Therapy for Lung Adenocarcinoma
por: Yu, Xiaozhou, et al.
Publicado: (2021)

Utilization of hypoxia-derived gene signatures to predict clinical outcomes and immune checkpoint blockade therapy responses in prostate cancer
por: Chen, Minhua, et al.
Publicado: (2022)

A Prognostic Signature for Clear Cell Renal Cell Carcinoma Based on Ferroptosis-Related lncRNAs and Immune Checkpoints
por: Dong, Yunze, et al.
Publicado: (2022)

A Novel Six Autophagy-Related Genes Signature Associated With Outcomes and Immune Microenvironment in Lower-Grade Glioma
por: Lin, Tao, et al.
Publicado: (2021)

Dissecting the Role of Immune Checkpoint Regulation Patterns in Tumor Microenvironment and Prognosis of Gastric Cancer
por: Zhen, Zili, et al.
Publicado: (2022)

DNA Damage Repair-Related Genes Signature for Immune Infiltration and Outcome in Cervical Cancer
por: Wang, Xinghao, et al.
Publicado: (2022)

An oxidative stress-related prognostic signature for indicating the immune status of oral squamous cell carcinoma and guiding clinical treatment
por: Lu, Wei, et al.
Publicado: (2022)

An Individualized Prognostic Signature for Clinically Predicting the Survival of Patients With Bladder Cancer
por: Liu, Qing, et al.
Publicado: (2022)

Identification and validation of a hypoxia-immune signature for overall survival prediction in lung adenocarcinoma
por: Li, Yong, et al.
Publicado: (2022)

EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

Development of an exosome-related and immune microenvironment prognostic signature in colon adenocarcinoma
por: Cui, Guoliang, et al.
Publicado: (2022)

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
por: Guo, Dina, et al.
Publicado: (2020)

GBP2 as a potential prognostic predictor with immune-related characteristics in glioma
por: Li, Ren, et al.
Publicado: (2022)

Identification of pyroptosis-related immune signature and drugs for ischemic stroke
por: Shi, Shanshan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9kq7fij1lomp9qclbpb3rk5tdf